{"id":103611,"date":"2026-04-02T06:23:10","date_gmt":"2026-04-02T04:23:10","guid":{"rendered":"https:\/\/www.infokuryr.cz\/n\/?p=103611"},"modified":"2026-04-02T06:23:10","modified_gmt":"2026-04-02T04:23:10","slug":"rusko-testuje-prulomovou-lecbu-rakoviny","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2026\/04\/02\/rusko-testuje-prulomovou-lecbu-rakoviny\/","title":{"rendered":"Rusko testuje pr\u016flomovou l\u00e9\u010dbu rakoviny"},"content":{"rendered":"
<\/div>\n

Personalizovan\u00fd l\u00e9k bude \u0159e\u0161it melanom ve t\u0159et\u00edm st\u00e1diu u pacienta a v\u00fdsledky se o\u010dek\u00e1vaj\u00ed v nadch\u00e1zej\u00edc\u00edch m\u011bs\u00edc\u00edch<\/h3>\n

Rusk\u00fd pacient s melanomem dostal prvn\u00ed personalizovanou vakc\u00ednu proti rakovin\u011b, co\u017e by m\u011blo b\u00fdt pr\u016flomem v l\u00e9\u010db\u011b t\u00e9to nemoci, uvedlo ve st\u0159edu rusk\u00e9 ministerstvo zdravotnictv\u00ed ve st\u0159edu prohl\u00e1\u0161en\u00ed pro agenturu TASS.<\/span><\/p>\n

Ministerstvo loni schv\u00e1lilo dva l\u00e9ky vyroben\u00e9 v tuzemsku: Neooncovac, vakc\u00ednu na b\u00e1zi mRNA pro pokro\u010dil\u00fd melanom, a Oncopept, peptidovou l\u00e9\u010dbu zam\u011b\u0159enou na agresivn\u00ed kolorekt\u00e1ln\u00ed n\u00e1dory. Oba za\u010daly pilotn\u00ed studie na lidech v roce 2025.<\/span><\/p>\n

V \u00fater\u00fd byl Neooncovac pod\u00e1n sv\u00e9mu prvn\u00edmu klinick\u00e9mu pacientovi, 60let\u00e9mu mu\u017ei s rakovinou k\u016f\u017ee ve t\u0159et\u00edm st\u00e1diu, uvedl Alexandr Ginzburg, v\u011bdeck\u00fd \u0159editel Gamalejina v\u00fdzkumn\u00e9ho \u00fastavu epidemiologie a mikrobiologie, kter\u00fd pomohl vyvinout tento pr\u016flomov\u00fd protin\u00e1dorov\u00fd l\u00e9k.<\/span><\/p>\n

\u201eZat\u00edm se mu da\u0159\u00ed dob\u0159e; na l\u00e9k se nevyskytly \u017e\u00e1dn\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky,\u201c<\/span><\/em>\u00a0\u0159ekl Ginzburg ve st\u0159edu rusk\u00e9mu zpravodajsk\u00e9mu port\u00e1lu Gazeta.ru.\u00a0<\/span>\u201eJe mu 60 let a m\u00e1 melanom t\u0159et\u00edho st\u00e1dia s metast\u00e1zami. Vakc\u00edna konkr\u00e9tn\u011b pom\u00e1h\u00e1 v boji proti metast\u00e1z\u00e1m.\u201c<\/span><\/em><\/p>\n

Vzorky byly odebr\u00e1ny z n\u00e1dorov\u00e9 i nen\u00e1dorov\u00e9 tk\u00e1n\u011b pacienta a v\u011bdci analyzovali genom, aby vytvo\u0159ili vakc\u00ednu na m\u00edru, kter\u00e1 tr\u00e9nuje imunitn\u00ed syst\u00e9m k \u00fatoku na rakovinn\u00e9 bu\u0148ky, vysv\u011btlil Ginzburg.<\/span><\/p>\n

Podle Andreye Kaprina, vedouc\u00edho N\u00e1rodn\u00edho l\u00e9ka\u0159sk\u00e9ho v\u00fdzkumn\u00e9ho centra radiologie rusk\u00e9ho ministerstva zdravotnictv\u00ed, p\u0159edstavuje tento p\u0159\u00edstup novou metodu l\u00e9\u010dby.<\/span><\/p>\n

\u201eToto je z\u00e1sadn\u011b odli\u0161n\u00fd p\u0159\u00edstup \u2013 nejde jen o l\u00e9\u010dbu nemoci, ale o \u201atr\u00e9nink\u2018 imunitn\u00edho syst\u00e9mu, aby rozpoznal a zni\u010dil p\u0159esn\u011b ty bu\u0148ky, kter\u00e9 p\u0159edstavuj\u00ed hrozbu,\u201c<\/span><\/em>\u00a0\u0159ekl ve st\u0159edu agentu\u0159e TASS.<\/span><\/p>\n

Pacientovi bude pod\u00e1no 8\u20139 d\u00e1vek l\u00e9ku v intervalech 2\u20133 t\u00fddn\u016f a po ka\u017ed\u00e9 injekci bude zaznamen\u00e1na jeho imunitn\u00ed odpov\u011b\u010f. V\u00fdsledky se o\u010dek\u00e1vaj\u00ed po t\u0159ech m\u011bs\u00edc\u00edch l\u00e9\u010dby.<\/span><\/p>\n

Ginzburg ji\u017e d\u0159\u00edve uvedl, \u017ee p\u0159edklinick\u00e9 studie na zv\u00ed\u0159atech uk\u00e1zaly, \u017ee n\u00e1dory v mnoha p\u0159\u00edpadech miz\u00ed, p\u0159i\u010dem\u017e metast\u00e1zy reagovaly v p\u0159ibli\u017en\u011b 90 % test\u016f.<\/span><\/p>\n

Vakc\u00edna Neooncovac je v sou\u010dasn\u00e9 dob\u011b v z\u00e1v\u011bre\u010dn\u00e9 f\u00e1zi zp\u0159\u00edstupn\u011bn\u00ed k bezplatn\u00e9 l\u00e9\u010db\u011b v r\u00e1mci rusk\u00e9ho syst\u00e9mu n\u00e1rodn\u00edho zdravotn\u00edho poji\u0161t\u011bn\u00ed, \u0159ekl ve st\u0159edu novin\u00e1\u0159\u016fm ministr zdravotnictv\u00ed Michail Mura\u0161ko.<\/span><\/p>\n

Gamaleyovo centrum, kter\u00e9 vyrobilo prvn\u00ed registrovanou vakc\u00ednu proti covidu-19, Sputnik V, pracuje tak\u00e9 na l\u00e9c\u00edch zam\u011b\u0159en\u00fdch na dal\u0161\u00ed onkologick\u00e1 onemocn\u011bn\u00ed, v\u010detn\u011b karcinomu slinivky b\u0159i\u0161n\u00ed, ledvin a nemalobun\u011b\u010dn\u00e9ho karcinomu plic \u2013 jednoho z druh\u016f rakoviny s nejvy\u0161\u0161\u00ed \u00famrtnost\u00ed na sv\u011bt\u011b.<\/span><\/p>\n

\"\"<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Personalizovan\u00fd l\u00e9k bude \u0159e\u0161it melanom ve t\u0159et\u00edm st\u00e1diu u pacienta a v\u00fdsledky se o\u010dek\u00e1vaj\u00ed v…<\/p>\n","protected":false},"author":2,"featured_media":103612,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[1453,1366,22],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/103611"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=103611"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/103611\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/103612"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=103611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=103611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=103611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}